Hence, the orexin system presents a unique opportunity to address the complex interplay between SUD, chronic pain, and sleep disturbances. Orexin receptor antagonists, particularly Dual Orexin Receptor Antagonists (DORAs) that are FDA-approved for treating insomnia, show considerable promise as novel ...